KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $121.0 million.

  • Abbott Laboratories' Interest Expenses fell 1478.87% to $121.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $509.0 million, marking a year-over-year decrease of 1254.3%. This contributed to the annual value of $559.0 million for FY2024, which is 1224.49% down from last year.
  • Per Abbott Laboratories' latest filing, its Interest Expenses stood at $121.0 million for Q3 2025, which was down 1478.87% from $121.0 million recorded in Q2 2025.
  • Abbott Laboratories' 5-year Interest Expenses high stood at $166.0 million for Q3 2023, and its period low was $121.0 million during Q2 2025.
  • For the 5-year period, Abbott Laboratories' Interest Expenses averaged around $140.0 million, with its median value being $136.0 million (2024).
  • Its Interest Expenses has fluctuated over the past 5 years, first surged by 2045.45% in 2023, then crashed by 1478.87% in 2025.
  • Quarter analysis of 5 years shows Abbott Laboratories' Interest Expenses stood at $131.0 million in 2021, then increased by 17.56% to $154.0 million in 2022, then grew by 3.25% to $159.0 million in 2023, then dropped by 14.47% to $136.0 million in 2024, then dropped by 11.03% to $121.0 million in 2025.
  • Its last three reported values are $121.0 million in Q3 2025, $121.0 million for Q2 2025, and $131.0 million during Q1 2025.